523 related articles for article (PubMed ID: 24858274)
61. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.
Shioya M; Obayashi S; Tabunoki H; Arima K; Saito Y; Ishida T; Satoh J
Neuropathol Appl Neurobiol; 2010 Jun; 36(4):320-30. PubMed ID: 20202123
[TBL] [Abstract][Full Text] [Related]
62. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
63. Assessing Genetic Overlap Between Platelet Parameters and Neurodegenerative Disorders.
Tirozzi A; Izzi B; Noro F; Marotta A; Gianfagna F; Hoylaerts MF; Cerletti C; Donati MB; de Gaetano G; Iacoviello L; Gialluisi A
Front Immunol; 2020; 11():02127. PubMed ID: 33117333
[TBL] [Abstract][Full Text] [Related]
64. Neurodegenerative Disorders Treatment: The MicroRNA Role.
Ridolfi B; Abdel-Haq H
Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
[TBL] [Abstract][Full Text] [Related]
65. MicroRNAs and deregulated gene expression networks in neurodegeneration.
Sonntag KC
Brain Res; 2010 Jun; 1338():48-57. PubMed ID: 20380815
[TBL] [Abstract][Full Text] [Related]
66. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT
J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352
[TBL] [Abstract][Full Text] [Related]
67. The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review.
Danborg PB; Simonsen AH; Waldemar G; Heegaard NH
Biomarkers; 2014 Jun; 19(4):259-68. PubMed ID: 24678935
[TBL] [Abstract][Full Text] [Related]
68. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
Duarte FV; Palmeira CM; Rolo AP
Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
[TBL] [Abstract][Full Text] [Related]
69. Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease.
Lu J; Xu Y; Quan Z; Chen Z; Sun Z; Qing H
Neuroscience; 2017 Dec; 365():70-82. PubMed ID: 28964753
[TBL] [Abstract][Full Text] [Related]
70. In search of genes involved in neurodegenerative disorders.
Pardo LM; van Duijn CM
Mutat Res; 2005 Dec; 592(1-2):89-101. PubMed ID: 16009383
[TBL] [Abstract][Full Text] [Related]
71. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
72. Gene networks in neurodegenerative disorders.
Recabarren D; Alarcón M
Life Sci; 2017 Aug; 183():83-97. PubMed ID: 28623007
[TBL] [Abstract][Full Text] [Related]
73. MicroRNAs as biomarkers of disease onset.
Ciesla M; Skrzypek K; Kozakowska M; Loboda A; Jozkowicz A; Dulak J
Anal Bioanal Chem; 2011 Oct; 401(7):2051-61. PubMed ID: 21544542
[TBL] [Abstract][Full Text] [Related]
74. Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases.
Zhang J; Chen Z; Chen H; Deng Y; Li S; Jin L
Biosensors (Basel); 2022 Nov; 12(12):. PubMed ID: 36551041
[TBL] [Abstract][Full Text] [Related]
75. Olfactory Dysfunction in Neurodegenerative Diseases.
Marin C; Vilas D; Langdon C; Alobid I; López-Chacón M; Haehner A; Hummel T; Mullol J
Curr Allergy Asthma Rep; 2018 Jun; 18(8):42. PubMed ID: 29904888
[TBL] [Abstract][Full Text] [Related]
76. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
[TBL] [Abstract][Full Text] [Related]
77. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease.
Pantiya P; Thonusin C; Chattipakorn N; Chattipakorn SC
Mitochondrion; 2020 Nov; 55():14-47. PubMed ID: 32828969
[TBL] [Abstract][Full Text] [Related]
78. Epigenetics in Parkinson's and Alzheimer's diseases.
Marques S; Outeiro TF
Subcell Biochem; 2013; 61():507-25. PubMed ID: 23150265
[TBL] [Abstract][Full Text] [Related]
79. [Treatment-Quo vadis neurodegeneration?].
Vöglein J; Levin J; Höglinger G
Nervenarzt; 2023 Oct; 94(10):904-912. PubMed ID: 37801166
[TBL] [Abstract][Full Text] [Related]
80. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
